Neoadjuvant therapy with Herceptin [trastuzumab] and Taxol [paclitaxel] for stage II/III breast cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2017
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Paclitaxel; Trastuzumab
- Indications Breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2009 Actual patient number (41) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov.